Rohto Pharmaceutical Co (TSE:4527) Days Sales Outstanding : 59.01 (As of Dec. 2023)

View and export this data going back to 1962. Start your Free Trial

What is Rohto Pharmaceutical Co Days Sales Outstanding?

Rohto Pharmaceutical Co's average Accounts Receivable for the three months ended in Dec. 2023 was 円47,400 Mil. Rohto Pharmaceutical Co's Revenue for the three months ended in Dec. 2023 was 円73,294 Mil. Hence, Rohto Pharmaceutical Co's Days Sales Outstanding for the three months ended in Dec. 2023 was 59.01.

The historical rank and industry rank for Rohto Pharmaceutical Co's Days Sales Outstanding or its related term are showing as below:

TSE:4527' s Days Sales Outstanding Range Over the Past 10 Years
Min: 55.82 Med: 70.9 Max: 86.63
Current: 60.46

During the past 13 years, Rohto Pharmaceutical Co's highest Days Sales Outstanding was 86.63. The lowest was 55.82. And the median was 70.90.

TSE:4527's Days Sales Outstanding is ranked worse than
75.54% of 1840 companies
in the Consumer Packaged Goods industry
Industry Median: 39.1 vs TSE:4527: 60.46

Rohto Pharmaceutical Co's Days Sales Outstanding increased from Dec. 2022 (58.31) to Dec. 2023 (59.01).

Rohto Pharmaceutical Co Days Sales Outstanding Historical Data

The historical data trend for Rohto Pharmaceutical Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rohto Pharmaceutical Co Days Sales Outstanding Chart

Rohto Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Sales Outstanding

Get a 7-Day Free Trial

68.82

63.09

64.62

58.98

55.82

Rohto Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															58.31	61.43	59.03	57.89	59.01

Competitive Comparison of Rohto Pharmaceutical Co's Days Sales Outstanding

For the Household & Personal Products subindustry, Rohto Pharmaceutical Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rohto Pharmaceutical Co's Days Sales Outstanding Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Rohto Pharmaceutical Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Rohto Pharmaceutical Co's Days Sales Outstanding falls into.

Rohto Pharmaceutical Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Rohto Pharmaceutical Co's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

	Days Sales Outstanding (A: Mar. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2022 )	+	Accounts Receivable (A: Mar. 2023 ))	/	count )	/	Revenue (A: Mar. 2023 )	*	Days in Period
=	( (33310	+	39686)	/	2 )	/	238664	*	365
=	36498					/	238664	*	365
=	55.82

Rohto Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (45177	+	49622)	/	2 )	/	73294	*	365 / 4
=	47399.5					/	73294	*	365 / 4
=	59.01

Rohto Pharmaceutical Co (TSE:4527) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Rohto Pharmaceutical Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Rohto Pharmaceutical Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Rohto Pharmaceutical Co (TSE:4527) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Rohto Pharmaceutical Co Ltd (TSE:4527) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

4527:Mexico

Address

1-8-1, Tatsumi-nishi, Ikuno-ku, Osaka, JPN, 544-8666

Website

https://www.rohto.co.jp

Rohto Pharmaceutical Co Ltd is a Japan-based manufacturer and marketer of pharmaceutical products, cosmetics, and functional foods. It undertakes manufacture and sales activities mainly in the health and beauty care categories. The company comprises the four geographical reportable segments of Japan, America, Europe, and Asia. In each segment, it manufactures and sales eye care products including eye drops and eyewash preparations, skincare products including dermal medicines, lip balm, sunscreens, and functional cosmetics, among others, internal medicines and food products including gastrointestinal medicines, traditional Chinese herbal medicines and supplements, and other products and services, such as in-vitro test kits.

Rohto Pharmaceutical Co (TSE:4527) Headlines

No Headlines